cost-effectiveness

November 26, 2018

UK’s NICE Recommends Against Lynparza Tablets on NHS for Advanced, Platinum-sensitive Ovarian Cancers

News

The U.K.’s National Institute of Health and Care Excellence (NICE) has decided not to recommend Lynparza (olaparib) tablets as maintenance treatment for women with relapsed ovarian cancer who respond to platinum-based chemotherapy ... Read more

July 17, 2017July 17, 2017

Preventive Mastectomies Provide Little Survival Benefit for Ovarian Cancer Patients, Study Finds

News

Mastectomies and the removal of ovaries and fallopian tubes are considered preventive measures for women carrying BRCA genetic mutations linked to breast and ovarian cancer. But for women who have already had ... Read more

July 13, 2016July 13, 2016

Researchers Suggest Lowering Guildelines for Pre-emptive Surgery Against Ovarian Cancer

News

UK researchers have recently suggested that the current guidelines for women to receive risk-reducing salpingo-oophorectomy (RRSO) should be re-evaluated in order to allow the cost-effective and lifesaving procedure for women with as little ... Read more